Recruiting
Phase 3

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

Sponsor:

Pfizer

Code:

NCT05611801

Conditions

Hemophilia A

Hemophilia B

Eligibility Criteria

Sex: Male

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

marstacimab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information